Benzinga | Oct 29, 2020 04:10PM EDT

PTC Therapeutics Q3 EPS $(1.03) Misses $(0.04) Estimate, Sales $118.40M Beat $111.88M Estimate

PTC Therapeutics (NASDAQ:PTCT) reported quarterly losses of $(1.03) per share which missed the analyst consensus estimate of $(0.04) by 2475 percent. This is a 2.83 percent increase over losses of $(1.06) per share from the same period last year. The company reported quarterly sales of $118.40 million which beat the analyst consensus estimate of $111.88 million by 5.83 percent. This is a 65.79 percent increase over sales of $71.42 million the same period last year.